Genedrive PLC
LSE:GDR
Genedrive PLC
Cash from Financing Activities
Genedrive PLC
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
G
|
Genedrive PLC
LSE:GDR
|
Cash from Financing Activities
£2.9m
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
54%
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Cash from Financing Activities
£64.7m
|
CAGR 3-Years
-26%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Cash from Financing Activities
-£1.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Diaceutics PLC
LSE:DXRX
|
Cash from Financing Activities
-£191k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Ergomed PLC
LSE:ERGO
|
Cash from Financing Activities
-£2.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
hVIVO PLC
LSE:HVO
|
Cash from Financing Activities
-£3.5m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-26%
|
See Also
What is Genedrive PLC's Cash from Financing Activities?
Cash from Financing Activities
2.9m
GBP
Based on the financial report for Dec 31, 2023, Genedrive PLC's Cash from Financing Activities amounts to 2.9m GBP.
What is Genedrive PLC's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
54%
The average annual Cash from Financing Activities growth rates for Genedrive PLC have been -23% over the past three years , -12% over the past five years , and 54% over the past ten years .